News
Eli Lilly nears $1.3B deal for Verve Therapeutics
Digest more
Stock futures were falling Tuesday and oil prices rose as Israel and Iran continued to exchange missile attacks and President ...
The rumored acquisition represents a natural progression of the existing partnership between Eli Lilly and Verve Therapeutics that began in mid-2023. Initially focused on advancing Verve’s in vivo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback